Insights from triggers and prodromal symptoms on how migraine attacks start: The threshold hypothesis
Gabriele Sebastianelli(Sapienza University of Rome), Patricia Pozo‐Rosich(Vall d'Hebron Institut de Recerca), Ilaria Cetta(Vita-Salute San Raffaele University), Hulya Karatas-Kurşun(Institute of Neurological Sciences), Arife Çimen Atalar(University of Southern Denmark), Mira Pauline Fitzek(Berlin Institute of Health at Charité - Universitätsmedizin Berlin), Aleksandar Pantovic(University of Belgrade), Dilara Onan(Yozgat Bozok Üniversitesi), Edoardo Caronna(Universitat Autònoma de Barcelona), Danilo Antonio Montisano(Fondazione IRCCS Istituto Neurologico Carlo Besta), Fatemeh Farham(Iran University of Medical Sciences), Jeva Skarlet(East Tallinn Central Hospital), Marharyta Kholodova(Kyiv City Clinical Oncology Center), Kadri-Hebo Kukumägi(Tartu University Hospital), Dmytro Dmytrovych Sotnikov(Sumy State University)
Cited by 20
Related Papers
In vitro comparison of the photothermal anticancer activity of graphene nanoparticles and carbon nanotubes
|Biomaterials|2010|560
Guidelines of the International Headache Society for controlled trials of preventive treatment of chronic migraine in adults
|Cephalalgia|2018|382
Genome-wide association analysis identifies susceptibility loci for migraine without aura
|Nature Genetics|2012|353
Guillain-Barré syndrome related to COVID-19 infection
|Neurology Neuroimmunology & Neuroinflammation|2020|340